Dr. Hanna Jabbour, CEO, Vitalis Family Health • 2026-05-27 • Women’s Health • 9 minutes readPerimenopause can bring new or worsening anxiety, depression, and insomnia.
A patient recently sat down in my office and said, “I think I’m losing it. I’ve never been an anxious person. I’m not sleeping. I cry over commercials. My doctor told me my labs are normal.”
Introduction
She was 46. She wasn’t losing it. She was in perimenopause.
The years leading up to the final menstrual period, typically a four-to-eight-year stretch beginning in the mid-40s, can bring a constellation of neuropsychiatric symptoms that catch many women completely off guard: new-onset anxiety, depressed mood, irritability, brain fog, and insomnia that doesn’t respond to any of the things that used to work. These symptoms are real, they are biologically grounded, and they are treatable.
This post walks through what we actually know about why this happens and what helps, drawing on guidance from The Menopause Society and recent systematic reviews, with an integrative lens.
Why perimenopause hits the brain so hard
Estrogen and progesterone don’t just regulate the reproductive system. They are powerful neuromodulators, with receptors throughout the brain, particularly in regions that govern mood, anxiety, sleep, temperature regulation, and cognition.
During perimenopause, estrogen levels don’t simply decline. They fluctuate wildly, often with widening, unpredictable swings before the eventual drop. Progesterone, which has direct calming effects through the GABA system, typically falls earlier and more steadily. The result is a brain trying to operate on a hormonal signal that has become noisy and inconsistent.[1]
The downstream effects include:
- Disruption of GABA-A receptor balance, contributing to anxiety and sleep fragmentation
- Altered serotonin signaling, contributing to depressive symptoms and vasomotor instability
- Reduced slow-wave and REM sleep, even before night sweats begin
- Heightened cortisol reactivity to stress
Women with prior histories of premenstrual mood symptoms, postpartum depression, or major depression are at substantially higher risk of perimenopausal mood episodes. If you’ve been here before, you are not imagining the pattern.
What about hormone therapy?
This is where the conversation has evolved significantly in the last few years.
The current evidence on systemic estrogen therapy specifically for treating perimenopausal mood disorders is mixed. Recent 2024–2025 systematic reviews concluded that the available evidence does not support a uniform recommendation for estrogen-based hormone therapy as a primary antidepressant for menopausal women. However, modest benefits have been observed in symptomatic women within a few years of their final menstrual period, particularly when other menopausal symptoms (vasomotor symptoms, sleep disruption) are also driving the mood disturbance.[2][3]
There’s a more interesting signal in combination approaches. A 2023 network meta-analysis found that adding systemic estradiol to an SSRI such as fluoxetine yielded markedly higher response and remission rates than either alone in this population.[4]
What this means in practice:
- HRT is not a first-line antidepressant, but it is also not “off the table” for mood symptoms, especially in early perimenopause when vasomotor and sleep symptoms are also present.
- Transdermal estradiol (patches, gels) is generally preferred over oral estrogen because of a more favorable cardiovascular and thrombotic risk profile.
- Micronized progesterone, dosed at bedtime, has independent calming and sleep-promoting effects in many women.
- A careful conversation about personal and family history (breast cancer, clotting, cardiovascular disease, migraine) is essential. HRT is not appropriate for everyone, and a thoughtful decision requires individualized risk-benefit framing.
This is exactly the kind of conversation a primary care or integrative physician should be having with you in detail, not in five minutes between other concerns.
CBT-I: the most underused treatment for menopausal insomnia
Recent systematic reviews and randomized trials have consistently demonstrated that CBT-I (cognitive behavioral therapy for insomnia) significantly improves sleep quality and reduces insomnia severity in menopausal women, and that, in head-to-head comparisons, CBT-I outperforms venlafaxine, escitalopram, yoga, aerobic exercise, omega-3 supplementation, and even estradiol for insomnia outcomes. Improvements persist for at least six months after treatment ends.[5][6]
CBT-I is now considered first-line treatment for insomnia in midlife women by sleep medicine and menopause specialty societies. It can be delivered in person, by video, by telephone, or through validated digital programs. It is not “sleep hygiene tips”, it is a structured, time-limited (typically 4–8 sessions) intervention with specific behavioral and cognitive components, including sleep restriction, stimulus control, and cognitive restructuring around catastrophic thoughts about sleep.
CBT for mood and vasomotor symptoms
A modified form of CBT specifically for menopausal symptoms has also accumulated good evidence for improving mood, reducing distress around hot flashes, and improving overall quality of life, even when the hot flashes themselves don’t fully resolve. The change in how the symptoms feel is often as meaningful as a change in their frequency.[7]
Lifestyle: the boring fundamentals that move the needle
I know “exercise, eat well, manage stress” is unsatisfying advice. But the evidence here is real, and the effect sizes are often larger than people expect.
Movement. Regular aerobic exercise (150 minutes/week of moderate-intensity activity) reduces depression and anxiety symptoms in midlife women, improves sleep architecture, supports cardiovascular and metabolic health, and protects against bone loss. Resistance training twice weekly adds independent benefits, particularly for body composition, insulin sensitivity, and mood. Walking counts.
Protein and stable blood sugar. Many women in perimenopause are under-fueled, particularly at breakfast, which contributes to mid-morning anxiety surges and afternoon energy crashes that get attributed to “hormones.” Aim for 25–35 g of protein at breakfast. Your nervous system will notice.
Caffeine and alcohol. Both worsen sleep fragmentation, night sweats, and anxiety in many perimenopausal women. This is rarely the news anyone wants, but reducing or eliminating evening alcohol is one of the highest-yield interventions I recommend.
Stress regulation practices. Daily mindfulness, paced breathing, yoga, or other contemplative practices have measurable effects on autonomic balance and HPA-axis reactivity. The specific practice matters less than the consistency.
Supplements: what has the most signal
The supplement aisle for perimenopause is a marketing free-for-all. A more conservative read of the literature:
Magnesium. Particularly magnesium glycinate or threonate at bedtime, has reasonable evidence for sleep and anxiety support, is generally well tolerated, and is helpful for restless legs and constipation. Typical dose: 200–400 mg in the evening. Check kidney function before sustained higher dosing.
Vitamin D. Should be replete (ideally 25-OH vitamin D in the 60–80 ng/mL range). Deficiency contributes to mood symptoms, fatigue, and musculoskeletal pain.
Ashwagandha (Withania somnifera). An adaptogenic herb with multiple randomized trials supporting reductions in perceived stress, cortisol, and sleep onset latency. Avoid in pregnancy, hyperthyroidism, or with significant immunosuppression. Discuss with your physician if you are on other psychotropic or thyroid medications.
Black cohosh, soy isoflavones, evening primrose oil. Mixed evidence for vasomotor symptoms; weaker evidence for mood. Reasonable to discuss as part of a broader plan, but not first-line for depression or anxiety.
Omega-3 fatty acids. Useful for cardiovascular and inflammatory support; modest direct mood benefits at higher EPA-predominant doses.
I do not recommend self-prescribing herbal “hormone balancers”, many contain phytoestrogenic or unidentified bioactive compounds that can interact with thyroid medications, anticoagulants, and SSRIs.
When to seek prompt evaluation
Please contact a physician promptly if you are experiencing thoughts of self-harm or suicide, sudden severe mood changes, new neurologic symptoms, or are unable to function in your work or relationships. Perimenopausal depression is a real and treatable condition; it is not something to “wait out.”
If you’re in crisis, in the US you can call or text 988 to reach the Suicide and Crisis Lifeline.
The takeaway
Perimenopause is not a deficiency disease, and it is not a character flaw. It is a profound neuroendocrine transition that deserves the same diagnostic and therapeutic seriousness we bring to any other chronic, multi-system condition. The good news is that the toolkit hormone therapy, CBT and CBT-I, lifestyle, targeted supplementation, herbs, homeopathy and pharmacotherapy is substantial, and most women feel meaningfully better with a thoughtful plan.
If you’d like a longer, integrative conversation about your symptoms, our practice would welcome you.
Dr. Hanna Jabbour is the CEO and founding physician of Vitalis Family Health. This article is for educational purposes and does not constitute medical advice for any specific individual. Hormone therapy and prescription medications carry individualized risks and should be discussed with your own physician.
References
[1]International Journal of Innovative Research in Medical Science. Menopausal transition raises vulnerability for anxiety and depression disorders. IJIRMS
[2]Contemporary OB/GYN (2025). Estrogen therapy shows mixed mental health effects in menopause. Contemporary OB/GYN
[3]International Journal of Gynecology & Obstetrics (2025). The role of hormone replacement therapy in the management of perimenopausal mental health symptoms: a narrative review. Wiley
[4]PMC (2024). Hormone replacement therapy for menopausal mood swings and sleep quality: the current evidence. PMC
[5]Life (MDPI, 2024). The effectiveness of cognitive behavioral therapy on insomnia severity among menopausal women: a scoping review. MDPI / PMC
[6]The Menopause Society. Cognitive-behavioral therapy shows promise managing menopausal insomnia and hot flashes. Menopause Society Press Release
[7]PMC (2025). Cognitive behavioural therapy for menopausal symptoms: a systematic review of efficacy in improving quality of life. PMCWelcome to WordPress. This is your first post. Edit or delete it, then start writing!